Skip to main content
OpenTrials

Clinical trial condition

Stage III Pancreatic Cancer AJCC v8

Explore clinical trials studying Stage III Pancreatic Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

41 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Stage III Pancreatic Cancer AJCC v8 trial results

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

NCT06906562

Conditions
Advanced Pancreatic Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Ohio State University-Telemedicine Birmingham, Alabama, United States
  • Ohio State University-Telemedicine Mobile, Alabama, United States
  • Ohio State University Telemedicine Montgomery, Alabama, United States
  • Ohio State University-Telemedicine Anchorage, Alaska, United States
View all 109 locations
View Trial Details
Active, not recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, not recruiting

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT01585805

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Mercy Hospital Saint Louis St Louis, Missouri, United States
View Trial Details
Active, not recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

NCT04514497

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Yale University New Haven, Connecticut, United States
  • Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut, United States
View all 23 locations
View Trial Details
Active, not recruiting

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

NCT04340141

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 453 locations
View Trial Details

Related conditions